Cargando…
Characterization of the Cellular Output of a Point-of-Care Device and the Implications for Addressing Critical Limb Ischemia
Critical limb ischemia (CLI) is a terminal disease with high morbidity and healthcare costs due to limb loss. There are no effective medical therapies for patients with CLI to prevent amputation. Cell-based therapies are currently being investigated to address this unmet clinical need and have shown...
Autores principales: | Woodell-May, Jennifer E., Tan, Matthew L., King, William J., Swift, Matthew J., Welch, Zachary R., Murphy, Michael P., McKale, James M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652191/ https://www.ncbi.nlm.nih.gov/pubmed/26634187 http://dx.doi.org/10.1089/biores.2015.0006 |
Ejemplares similares
-
Potential Mechanism of Action of Current Point-of-Care Autologous Therapy Treatments for Osteoarthritis of the Knee—A Narrative Review
por: Woodell-May, Jennifer, et al.
Publicado: (2021) -
Review of the Latest Percutaneous Devices in Critical Limb Ischemia
por: Haghighat, Leila, et al.
Publicado: (2018) -
Distinct TP53 Mutation Subtypes Differentially Influence Cellular Iron Metabolism
por: Clarke, Stephen L., et al.
Publicado: (2019) -
HDAC inhibition induces EMT and alterations in cellular iron homeostasis to augment ferroptosis sensitivity in SW13 cells
por: Oliveira, Thais, et al.
Publicado: (2021) -
Influence of microRNA on the Maintenance of Human Iron Metabolism
por: Davis, McKale, et al.
Publicado: (2013)